Biology of dendritic cells;Biologia komórek dendrytycznych

Onkologia Polska

Volumn 11, Issue 3, 2008, Pages 106-110

  Kopeć Szlȩzak, Joanna ^a  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

Author keywords

Dendritic cells; Functions; Maturation; Subpopulations

Indexed keywords

EID: 79958176759     PISSN: 15056732     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Bancherau J., Briere F., Caux C.i wsp.: Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18, 767-811.
2. Wu L., Dakic A.: Development of dendritic cell system. Cell. Mol. Immunol. 2004, 1, 112-118.
3. Encabo A., Solves P., Mateu E. i wsp.: Selective generation of different dendritic precursors from CD34+ cell by interleukin-6 and interleukin-3. Stem Cells 2004, 22, 725-740. (Pubitemid 39166930)
4. Steinman RM.: Some interfaces of dendritic cell biology. APMIS 2003, 111, 675-697.
5. Dzionek A., Fuchs A., Schmidt P. i wsp.: BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 2000, 165, 6037-46.
6. Hellman P., Eriksson H.: Early activation markers of human peripheral dendritic cells. Hum. Immunol. 2007, 68, 324-333. (Pubitemid 46616974)
7. Robson N., Phillips D., McAlpine T. i wsp.: Activin-A: A novel dendritic cell derived cytokine which potently CD40 ligand-specifi c cytokine and chemkine production. Blood 2008, 111, 2733-2743.
8. Scholler N., Hayden-Ledbetter M., Dahlin A. i wsp.: CD83 regulates the development of cellular immunity. J. Immunol. 2002, 168, 2599-2607.
9. Tuyaerts S., Aerts J. Corthals J. i wsp.: Current approaches in dendritic cells generation and future implications for cancer immunotherapy. Cancer Immunol. Immunother. 2007, 56, 1513-38.
10. Barchet W., Cella M., Colonna M.: Plasmacytoid dendritic cellsvirus experts of innate immunity. Semin. Immunol. 2005, 17, 253-261. (Pubitemid 40981931)
11. Pilarisetty V.G., Katz S.C., Bleier J.I., Shah A.B., Dematteo R.P.: Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-γ via autocrine IL- 12. J. Immunol. 2005, 174, 2612-2618. (Pubitemid 40279674)
12. Chen L., Calomeni E., Wen J. i wsp.: Natural killer dendritic cells are an intermediate of developing dendritic cells. J. Leukoc. Biol. 2007, 81, 1422-1433. (Pubitemid 46827965)
13. Chaudry U., Plitas G., Burt B. i wsp.: NK Dendritic cells expanded in IL-15 exhibit antitumor responses in vivo. J. Immunol. 2007, 179, 4654-60.
14. Park C., Choi Y.: How do follicular dendritic cells interact intimately with B cells in the germinal centre? Immunology 2005, 114, 2-10. (Pubitemid 40030287)
15. Zeromski J., Samara H., Mozer-Lisewska I.: Komórki dendrytyczne: czy wszystko o nich wiemy? Post. Biol. Kom. 2007, 34, 541-556.
16. Cools N., Ponsaerts P., van Tandeloo V., Berneman Z.: Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells and effector T cells. J. Leukoc. Biol. 2007, 82, 1365-1374. (Pubitemid 350276946)
17. Hubert P. Jacobs N., Caberg J.H. i wsp.: The cross-talk between dendritic and regulatory cells. J. Leukoc. Biol. 2007, 82, 781-794.
18. Vlad G., Cortesini R., Suciu-Foca N.: License to heal: bidirectional interaction of antigen-specifi c regulatory T cells and tolerogenic APC. J. Immunol. 2005,174, 5907-5914. (Pubitemid 40663774)
19. Sauter B., Albert M., Francisco L. i wsp.: Consequences of cell death exposure to necrotic tumor cells, but not primary tissue cell or apoptotic cells induces the maturation of dendritic cells. J. Exp. Med. 2000, 191, 501-518.
20. Kalinski P., Mailliard R.B., Giermasz A. i wsp.: Natural killer-dendritic cell cross-talk in cancer immunotherapy. Expert Opin. Ther. 2005, 5, 1303-1315. (Pubitemid 41503042)
21. Boissel N., Rousselot P., Ratfour E. i wsp.: Defective blood dendritic cells in chronic myeloid leukemia correlates with high plasmatic VEGF. Leukemia 2004, 18, 1656-1661. (Pubitemid 39386344)
22. Orsini E., Guarini A., Chiaretti S. i wsp.: The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response. Cancer Res. 2003, 63, 4497-4506. (Pubitemid 36951022)
23. Wolf D., Tilg H., Rumpold H. i wsp.: The kinase inhibitor imanitiban immunosuppressive drug? Curr. Cancer Drug. Targets 2007, 7, 251-258. (Pubitemid 46699076)
24. Straube C., Wehner R., Wendisch M. i wsp.: Bortezomibsignificantly impairs immunostimulatory capacity of human myeloid blood dendritic cells. Leukemia 2007, 21, 1464-1471. (Pubitemid 46965288)
25. Taig N., Moses D., Gieseler S., Schauer U.: Age related changes in human blood dendritic cells population. Scand. J. Immunol. 2002, 55, 453-457. (Pubitemid 34451230)
26. Reddy V., Itturaspe J., Tzolas A. i wsp.: Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death and acute graft-versus host disease. Blood 2004, 103, 4330-4335. (Pubitemid 38685381)
27. Arpinati M., Chirumbolo G., Urbini B. i wsp.: Acute graft -versus host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation. Biol. Blood Marrow Transplant. 2004, 10, 106-115. (Pubitemid 38145864)
28. Szabo G., Dolganiuc A.: Subversion of plasmacytoid and myeloid dendritic cell functions in chronic HCV infection. Immunobiology 2005, 210, 237-247. (Pubitemid 41025165)
29. Lai W.K., Curbishley S., Goddard S.: Hepatitis c is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function. J. Hepatol. 2007, 47, 338-347. (Pubitemid 47176158)
30. Groot E., van Capel T.M., Kapsenberg M.L. i wsp.: Opposing role of blood myeloid and plasmacytoid dendritic cells in HIV-1 infection of T cells: transmission facilitation versus replication inhibition. Blood 2006, 108, 1957-64. (Pubitemid 44395006)